Dendritic cell vaccination for hepatocellular carcinoma.

Dendritic cell vaccination for hepatocellular carcinoma.

Dettagli Bibliografici
Autori principali:	Midgley, R, Palmer, D, Mirza, N, Steele, J, Steven, J, Kerr, D, Young, L, Adams, D
Natura:	Conference item
Pubblicazione:	2003

Documenti analoghi

A phase I/II dendritic cell (DC) immunotherapy trial for hepatocellular carcinoma (HC)
di: Midgley, R, et al.
Pubblicazione: (2002)

A Phase II trial of dendritic cell (DC) immunotherapy for hepatocellular carcinoma
di: Midgley, R, et al.
Pubblicazione: (2004)

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.
di: Palmer, D, et al.
Pubblicazione: (2009)

Identification of an oligopeptide binding to hepatocellular carcinoma.
di: Shimizu, A, et al.
Pubblicazione: (2006)

Comparison of monocyte versus CD34+precursors for the generation of clinical grade dendritic cells for immunotherapy protocols in hepatocellular carcinoma
di: Daniels, H, et al.
Pubblicazione: (2005)

Histopathological landmarks of hepatocellular carcinoma in Malaysians
di: Cheah, P.L., et al.
Pubblicazione: (2003)

T cells in HBV associated hepatocellular carcinoma and other cancers
di: Li, X
Pubblicazione: (2017)

Primary Hepatocellular carcinoma: management and prognosis
di: Murtaza Mustafa, et al.
Pubblicazione: (2016)

Global epidemiology and genetics of hepatocellular carcinoma
di: Toh, Ming Ren, et al.
Pubblicazione: (2023)

Expression of somatostatin receptors in hepatocellular carcinoma.
di: Tan, Hock Jin.
Pubblicazione: (2011)

Novel treatments for hepatocellular cancer.
di: Kerr, S, et al.
Pubblicazione: (2009)

Prevention of hepatocellular carcinoma in the Asia-Pacific region: Consensus statements
di: Farrell, G.C., et al.
Pubblicazione: (2010)

Trajectory of immune evasion and cancer progression in hepatocellular carcinoma
di: Nguyen, Phuong H. D., et al.
Pubblicazione: (2023)

CTP synthase forms the cytoophidium in human hepatocellular carcinoma
di: Chang, C, et al.
Pubblicazione: (2017)

Hepatocellular carcinoma with disseminated skeletal muscle metastasis
di: Abdul Rahim, Ezamin, et al.
Pubblicazione: (2017)

Bile acids as drivers and biomarkers of hepatocellular carcinoma
di: Colosimo, S, et al.
Pubblicazione: (2022)

Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis.
di: Snook, J, et al.
Pubblicazione: (1989)

Specific CD8+ T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis
di: Moreno-Cubero, E, et al.
Pubblicazione: (2016)

Cytotoxicity of Goniothalamin on the Human Hepatocellular Carcinoma HEPG2 Cell Line
di: Obaid Al-Qubaisi, Mothanna Sadiq
Pubblicazione: (2009)

Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
di: He, Michelle J., et al.
Pubblicazione: (2022)

Activation of human dendritic cells for immunotherapy in ovarian carcinoma
di: Brencicova, E, et al.
Pubblicazione: (2012)

Wnt Signaling Pathway Related Genes In Hepatocellular Carcinoma
di: Ban, Kechen
Pubblicazione: (2002)

Human hepatocellular carcinoma diagnosis by multiphoton autofluorescence microscopy
di: So, Peter T. C., et al.
Pubblicazione: (2010)

Novel markers of cell kinetics to evaluate progression from cirrhosis to hepatocellular carcinoma.
di: Quaglia, A, et al.
Pubblicazione: (2006)

Tumour seeding following percutaneous needle biopsy of hepatocellular carcinoma
di: Qua, C.S., et al.
Pubblicazione: (2008)

Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study.
di: Sun, Z, et al.
Pubblicazione: (1991)

Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages
di: Zang, C, et al.
Pubblicazione: (2021)

NEIL1 protects against aflatoxin-induced hepatocellular carcinoma in mice
di: Vartanian, Vladimir, et al.
Pubblicazione: (2018)

Targeted inhibition of purine metabolism is effective in suppressing hepatocellular carcinoma progression
di: Chong, Yong Chun, et al.
Pubblicazione: (2020)

Gastric Metastasis from Hepatocellular Carcinoma: A Rare Manifestation
di: Abdul Hakim, Mohamed Seenikatty, et al.
Pubblicazione: (2018)

Mediastinal Hepatocellular Carcinoma with Unknown Primary: An Unusual and Rare Presentation
di: Koh, P.S., et al.
Pubblicazione: (2014)

Unravelling genetic heterogeneity of hepatocellular carcinoma with driver genes and subclones
di: Ng, Ming Hwee
Pubblicazione: (2015)

TACE and Continuous Intraarterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma
di: Perpustakaan UGM, i-lib
Pubblicazione: (1993)

An evolutionary and genomic approach to understand tumor evolution in hepatocellular carcinoma
di: Kaya, Arife Neslihan
Pubblicazione: (2021)

Therapeutic targeting of NAMPT and its associated pathways in hepatocellular carcinoma
di: Yeo, Joanna Zhen Zhen
Pubblicazione: (2022)

Targeted polymeric therapeutic nanoparticles: Design and interactions with hepatocellular carcinoma
di: Wang, Qi, et al.
Pubblicazione: (2016)

Percutaneous, non-operative radio frequency ablation for haemostasis of ruptured hepatocellular carcinoma
di: Manikam, J., et al.
Pubblicazione: (2009)

Proliferating cell nuclear antigen (PCNA) activity in hepatocellular carcinoma, benign peri-neoplastic and normal liver
di: Mun, K.S., et al.
Pubblicazione: (2006)

Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.
di: Hoshida, Y, et al.
Pubblicazione: (2009)

Regional differences in admissions and treatment outcomes for hepatocellular carcinoma patients in Thailand
di: Kitiyakara, T, et al.
Pubblicazione: (2022)